Karim Abid

2.4k total citations · 1 hit paper
35 papers, 1.8k citations indexed

About

Karim Abid is a scholar working on Epidemiology, Surgery and Hepatology. According to data from OpenAlex, Karim Abid has authored 35 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Epidemiology, 11 papers in Surgery and 11 papers in Hepatology. Recurrent topics in Karim Abid's work include Hepatitis C virus research (11 papers), Adrenal and Paraganglionic Tumors (11 papers) and Cancer, Hypoxia, and Metabolism (7 papers). Karim Abid is often cited by papers focused on Hepatitis C virus research (11 papers), Adrenal and Paraganglionic Tumors (11 papers) and Cancer, Hypoxia, and Metabolism (7 papers). Karim Abid collaborates with scholars based in Switzerland, United States and Italy. Karim Abid's co-authors include Francesco Negro, Claudio Soto, Rodrigo Morales, Laura Rubbia‐Brandt, Ralf Bartenschlager, François–Loïc Cosset, Marlène Dreux, Eike Steinmann, George Koutsoudakis and Anna Shavinskaya and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Karim Abid

33 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras

2006 588 citations Thomas Pietschmann, Artur Kaul et al. Proceedings of the National Academy of Sciences profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Karim Abid Switzerland	15	1.1k	1.1k	537	147	138	35	1.8k
Tadaomi Aikawa Japan	18	297 0.3×	289 0.3×	377 0.7×	13 0.1×	128 0.9×	49	1.4k
Rajagopal N. Aravalli United States	17	233 0.2×	353 0.3×	806 1.5×	178 1.2×	30 0.2×	37	1.6k
H. Rieder Germany	19	445 0.4×	318 0.3×	390 0.7×	16 0.1×	37 0.3×	68	1.3k
Dieter Häussinger Germany	18	150 0.1×	265 0.3×	326 0.6×	25 0.2×	34 0.2×	27	1.1k
Masahiro Iizuka Japan	14	147 0.1×	377 0.4×	577 1.1×	17 0.1×	23 0.2×	55	1.4k
Xuebin Dong United Kingdom	18	134 0.1×	173 0.2×	697 1.3×	32 0.2×	60 0.4×	44	1.4k
Maria Ripoli Italy	17	219 0.2×	271 0.3×	565 1.1×	21 0.1×	18 0.1×	23	1.1k
C.E. Hulstaert Netherlands	17	117 0.1×	106 0.1×	350 0.7×	27 0.2×	82 0.6×	38	1.2k
Marian A. van Roon Netherlands	14	207 0.2×	409 0.4×	979 1.8×	12 0.1×	14 0.1×	19	2.1k
Manuela Cappelletti Italy	16	54 0.0×	184 0.2×	528 1.0×	38 0.3×	50 0.4×	21	1.4k

Countries citing papers authored by Karim Abid

Since Specialization

Citations

This map shows the geographic impact of Karim Abid's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karim Abid with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karim Abid more than expected).

Fields of papers citing papers by Karim Abid

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karim Abid. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karim Abid. The network helps show where Karim Abid may publish in the future.

Co-authorship network of co-authors of Karim Abid

This figure shows the co-authorship network connecting the top 25 collaborators of Karim Abid. A scholar is included among the top collaborators of Karim Abid based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karim Abid. Karim Abid is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mansi, Rosalba, Raghuvir H. Gaonkar, Melpomeni Fani, et al.. (2023). CUDC-907, a dual PI3K/histone deacetylase inhibitor, increases meta-iodobenzylguanidine uptake (123/131I-mIBG) in vitro and in vivo: a promising candidate for advancing theranostics in neuroendocrine tumors. Journal of Translational Medicine. 21(1). 604–604. 3 indexed citations

Eugster, Philippe J., Karim Abid, Maurice Matter, et al.. (2022). Proneuropeptide Y and neuropeptide Y metabolites in healthy volunteers and patients with a pheochromocytoma or paraganglioma. Clinica Chimica Acta. 534. 146–155. 6 indexed citations

Mühlethaler‐Mottet, Annick, Silvia Uccella, Stefano La Rosa, et al.. (2022). Low number of neurosecretory vesicles in neuroblastoma impairs massive catecholamine release and prevents hypertension. Frontiers in Endocrinology. 13. 1027856–1027856. 2 indexed citations

Pivin, Edward, Alban Denys, Karim Abid, et al.. (2022). Accurate Location of Catheter Tip With the Free-to-Total Metanephrine Ratio During Adrenal Vein Sampling. Frontiers in Endocrinology. 13. 842968–842968. 8 indexed citations

Weiss, Benjamin, et al.. (2021). eIF4E3 forms an active eIF4F complex during stresses (eIF4FS) targeting mTOR and re-programs the translatome. Nucleic Acids Research. 49(9). 5159–5176. 22 indexed citations

Harris, Alan G., et al.. (2018). Cellular effects of AP102, a somatostatin analog with balanced affinities for the hSSTR2 and hSSTR5 receptors. Neuropeptides. 68. 84–89. 8 indexed citations

Abid, Karim, Katayoun Afshar, Samuel Rotman, et al.. (2016). Pheochromocytoma Masked by Mutation in the TH Gene. Clinical Chemistry. 62(7). 924–928.

Tuleasca, Constantin, Yves Jaquet, Valérie Schweizer, et al.. (2016). Clinical and biochemical responses after Gamma Knife surgery for a dopamine-secreting paraganglioma: case report. HORMONES. 15(1). 106–112. 3 indexed citations

Grouzmann, Eric, Oliver Tschopp, Frédéric Triponez, et al.. (2015). Catecholamine Metabolism in Paraganglioma and Pheochromocytoma: Similar Tumors in Different Sites?. PLoS ONE. 10(5). e0125426–e0125426. 24 indexed citations

10.

Grouzmann, Eric, Maurice Matter, Stefan Bilz, et al.. (2012). Monoamine Oxidase A Down-Regulation Contributes to High Metanephrine Concentration in Pheochromocytoma. The Journal of Clinical Endocrinology & Metabolism. 97(8). 2773–2781. 22 indexed citations

11.

Abid, Karim, Rodrigo Morales, & Claudio Soto. (2010). Cellular factors implicated in prion replication. FEBS Letters. 584(11). 2409–2414. 43 indexed citations

12.

Pietschmann, Thomas, Artur Kaul, George Koutsoudakis, et al.. (2006). Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras. Proceedings of the National Academy of Sciences. 103(19). 7408–7413. 588 indexed citations breakdown →

13.

Castilla, Joaquı́n, Paula Saá, Rodrigo Morales, et al.. (2006). Protein Misfolding Cyclic Amplification for Diagnosis and Prion Propagation Studies. Methods in enzymology on CD-ROM/Methods in enzymology. 412. 3–21. 114 indexed citations

14.

Morales, Rodrigo, Karim Abid, & Claudio Soto. (2006). The prion strain phenomenon: Molecular basis and unprecedented features. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1772(6). 681–691. 124 indexed citations

15.

Abid, Karim & Claudio Soto. (2006). The intriguing prion disorders. Cellular and Molecular Life Sciences. 63(19-20). 2342–2351. 36 indexed citations

16.

Liu, Rong, Karim Abid, John Pichardo, et al.. (2006). In vitro antiviral activity of SCH446211 (SCH6), a novel inhibitor of the hepatitis C virus NS3 serine protease. Journal of Antimicrobial Chemotherapy. 59(1). 51–58. 13 indexed citations

17.

Abid, Karim, Valerio Pazienza, Andrea De Gottardi, et al.. (2005). An in vitro model of hepatitis C virus genotype 3a-associated triglycerides accumulation. Journal of Hepatology. 42(5). 744–751. 142 indexed citations

18.

Abid, Karim, et al.. (2003). 134 In vitro antiviral activity of SCH6, a novel inhibitor of the hepatitis C virus NS3 serine protease. Hepatology. 38. 220–221. 1 indexed citations

19.

Rubbia‐Brandt, Laura, Sophia Taylor, Rafael Quadri, et al.. (2002). Lack of in vivo blockade of Fas‐ and TNFR1‐mediated hepatocyte apoptosis by the hepatitis C virus. The Journal of Pathology. 197(5). 617–623. 14 indexed citations

20.

Abid, Karim, et al.. (2000). A novel hepatitis C virus (HCV) subtype from Somalia and its classification into HCV clade 3. Journal of General Virology. 81(6). 1485–1493. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact